iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Sold by Kampmann Melissa S.

by · The Cerbat Gem

Kampmann Melissa S. reduced its position in iRhythm Technologies, Inc. (NASDAQ:IRTC – Free Report) by 8.4% in the 4th quarter, Holdings Channel.com reports. The fund owned 23,925 shares of the company’s stock after selling 2,190 shares during the quarter. Kampmann Melissa S.’s holdings in iRhythm Technologies were worth $2,157,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of IRTC. Xponance Inc. acquired a new stake in shares of iRhythm Technologies during the fourth quarter worth $203,000. Intech Investment Management LLC lifted its holdings in shares of iRhythm Technologies by 57.8% during the fourth quarter. Intech Investment Management LLC now owns 14,927 shares of the company’s stock worth $1,346,000 after purchasing an additional 5,467 shares during the period. Cibc World Markets Corp acquired a new stake in shares of iRhythm Technologies during the fourth quarter worth $264,000. Monimus Capital Management LP acquired a new stake in shares of iRhythm Technologies during the fourth quarter worth $1,051,000. Finally, Swiss National Bank lifted its holdings in shares of iRhythm Technologies by 1.2% during the fourth quarter. Swiss National Bank now owns 61,400 shares of the company’s stock worth $5,536,000 after purchasing an additional 700 shares during the period.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Canaccord Genuity Group increased their price target on iRhythm Technologies from $125.00 to $152.00 and gave the stock a “buy” rating in a report on Monday, December 9th. StockNews.com raised iRhythm Technologies from a “sell” rating to a “hold” rating in a report on Monday, February 24th. Needham & Company LLC raised their target price on iRhythm Technologies from $125.00 to $138.00 and gave the company a “buy” rating in a report on Friday, February 21st. Truist Financial raised their target price on iRhythm Technologies from $111.00 to $145.00 and gave the company a “buy” rating in a report on Friday, February 21st. Finally, Oppenheimer raised their target price on iRhythm Technologies from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Wednesday, January 8th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, iRhythm Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $119.73.

Get Our Latest Stock Analysis on IRTC

iRhythm Technologies Trading Up 1.4 %

Shares of IRTC stock opened at $103.11 on Thursday. iRhythm Technologies, Inc. has a fifty-two week low of $55.92 and a fifty-two week high of $128.52. The stock has a market cap of $3.24 billion, a P/E ratio of -28.33 and a beta of 1.36. The business has a fifty day simple moving average of $107.40 and a 200-day simple moving average of $88.28. The company has a quick ratio of 6.12, a current ratio of 6.27 and a debt-to-equity ratio of 9.00.

iRhythm Technologies (NASDAQ:IRTC – Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported $0.01 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.30. iRhythm Technologies had a negative return on equity of 118.83% and a negative net margin of 19.14%. The business had revenue of $164.33 million during the quarter, compared to analysts’ expectations of $158.30 million. On average, analysts forecast that iRhythm Technologies, Inc. will post -1.98 earnings per share for the current fiscal year.

About iRhythm Technologies

(Free Report)

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.

Featured Stories

Want to see what other hedge funds are holding IRTC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iRhythm Technologies, Inc. (NASDAQ:IRTC – Free Report).